CD4 and neoplasm: We demonstrate that the enhanced antitumor effect was associated with increased IFN-γ expression, induction of a tumor-specific immune response, recruitment of immune cells (CD4+, CD8+ T cells, DCs, and NK cells), and efficient prevention of tumor-induced thymic atrophy.